This is in line with data demonstrating that MCC950 reduces liver inflammation and fibrosis in experimental NASH in mice [64], and the that the livers of aged NLRP3 null mice exhibit less fibrosis and oxidative damage compared to their younger counterparts [65]. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.